Announcements Trials
Browse Landscape

Phase

Phase 2 163Phase 3 38Phase 1 32Phase 1/2 27Phase 2/3 6Phase 4 5Phase NA 3Phase EARLY_PHASE1 3

Status

Recruiting 3Not yet recruiting 1Completed 1

Sponsor Class

OTHER 4INDUSTRY 1

Study Type

Interventional 5

Sponsor

Cancer Type

Breast 5

Conditions

Carcinoma, Non-Small-Cell Lung 7Lung Neoplasms 5Breast Neoplasms 5Small Cell Lung Carcinoma 3Thoracic Neoplasms 2Ovarian Neoplasms 2Neuroendocrine Tumors 2Neoplasms 2Lung Diseases 2Carcinoma, Large Cell 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Retinoblastoma 1Respiratory Tract Neoplasms 1Respiratory Tract Diseases 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Non-small Cell Lung Cancer Metastatic 1Non-Small Cell Lung Cancer Metastatic 1Neoplasms, Second Primary 1Neoplasms by Site 1Nasopharyngeal Neoplasms 1NSCLC 1Medulloblastoma 1Carcinoma, Squamous Cell 1Carcinoma, Ovarian Epithelial 1Carcinoma, Bronchogenic 1Carcinoma 1Cancer Therapy-related Cardiovascular Toxicity 1Bronchial Neoplasms 1Adenocarcinoma of Lung 1

Interventions

Letrozole 20Docetaxel 16Cyclophosphamide 13Zoledronic Acid 12exemestane 11Trastuzumab 11Anastrozole 11Paclitaxel 10Tamoxifen 9Capecitabine 9Fulvestrant 8Epirubicin 8pegfilgrastim 7pertuzumab 6liposomal doxorubicin 6abemaciclib 6Saline Solution 6palbociclib 5Sodium Chloride 5Dexmedetomidine 5Carboplatin 5Bupivacaine 5Bevacizumab 5ribociclib 4pegylated granulocyte colony-stimulating factor 4eribulin 4Tranexamic Acid 4Standard of Care 4Pamidronate 4Filgrastim 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

5 trials
RecentStart dateEnrollment
Phase 4 × Breast Neoplasms × Carboplatin × Clear all
NCT07093931 2025-07-30

Efficacy and Safety of Lobaplatin and Carboplatin as Neoadjuvant Therapy in HER-2 Positive Breast Cancer

Shandong Cancer Hospital and Institute

Phase 4 Not yet recruiting
468 enrolled
Breast

Breast Neoplasms

NCT02419742 2022-10-12

Safety and Efficacy of Trastuzumab as Part of Breast Cancer Treatment Regimen

Hoffmann-La Roche

Phase 4 Completed
110 enrolled 10 charts
Breast

Breast Neoplasms

NCT05420454 2022-07-01

A Study for the Neoadjuvant Treatment of Breast Cancer

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 4 Recruiting
1,576 enrolled
Breast

Breast Neoplasms

NCT05420467 2022-07-01

A Study for the Adjuvant Treatment of Breast Cancer

Second Affiliated Hospital, School of Medicine, Zhejiang University

Phase 4 Recruiting
2,413 enrolled
Breast

Breast Neoplasms

NCT04136782 2021-07-20

Albumin-bound Paclitaxel and Carboplatin Versus Epirubicin and Docetaxel for Triple-negative Breast Cancer

Shengjing Hospital

Phase 4 Recruiting
110 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡